STOCK TITAN

BioRegenx (BRGX) Free Cash Flow by Year

BRGX OTC

BioRegenx Inc generated $30K in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters BioRegenx Inc has filed alongside them.

FY2025 annual
Free Cash Flow $30K
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BRGX Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
Free Cash Flow$30Kn/m-$514Kn/m-$1.5MN/AN/A

BRGX Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Free Cash FlowN/A$67Kn/m-$78Kn/m$3Kn/m$38Kn/m-$11Kn/m-$31K-$177K-$294Kn/m-$246KN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More BioRegenx Inc financials

Frequently Asked Questions

BioRegenx Inc generated $30K in free cash flow in fiscal year 2025.

BioRegenx Inc (BRGX) reported an outflow of $514K in free cash flow in fiscal year 2024 and $30K in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what BioRegenx Inc (BRGX) reported on that line in every period on record.